Inventor
Michael G. Campbell
Inventor
Durham, NC, US
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes25%
C07CAcyclic or carbocyclic compounds6%
H04LTransmission of digital information, e.g. telegraphic communication3%
H04QSelecting3%
PatentTitleYear
11,018,843Sensor communication control shaped for EMC compliance20218,129,424'Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders'20127,981,896'Pyrazoles for the treatment of obesity and other CNS disorders'20117,897,634'Pyrazoles for the treatment of obesity and other CNS disorders'20117,855,224'Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders'20107,528,262'Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders'20097,501,446'Prenylation inhibitors and methods of their synthesis and use'20097,319,103'Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders'20087,166,619'Prenylation inhibitors and methods of their synthesis and use'20076,919,366'Benzimidazole derivatives as modulators of IgE'20056,919,339'ABCA-1 elevating compounds'20056,911,462'Benzimidazole compounds for regulating IgE'20056,900,219'ABCA-1 elevating compounds'20056,548,548'ABCA-1 elevating compounds'20036,451,829'Coumarinic compounds having IgE affecting properties'20026,369,091'Benzimidazole analogs as down-regulators of IgE'20026,303,645'Benzimidazole derivatives as modulators of IgE'20016,271,390'Suppression of the IgE-dependent allergic response by benzimidazole analogs'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2005Patents assigned to AVANIR PHARMACEUTICALS (5)· patent assignee history
2001–2005Based in Durham, NC, US· patent location history
2003–2005Patents assigned to CV THERAPEUTICS INC (2)· patent assignee history
2007–2009Patents assigned to PPD DISCOVERY INC (2)· patent assignee history
2007–2011Based in Sagamore Hills, OH, US· patent location history
2008–2012Patents assigned to ATHERSYS INC (6)· patent assignee history
2011–2012Based in Thunder Bay, CA· patent location history
2012Patents assigned to BENNANI YOUSSEF L (1)· patent assignee history
2021Based in Canton, MI, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ATHERSYS INC | 6 | 2008–2012 |
| AVANIR PHARMACEUTICALS | 5 | 2001–2005 |
| CV THERAPEUTICS INC | 2 | 2003–2005 |
| PPD DISCOVERY INC | 2 | 2007–2009 |
| BENNANI YOUSSEF L | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Durham, NC, US | 9 | 2001–2005 |
| Sagamore Hills, OH, US | 6 | 2007–2011 |
| Thunder Bay, CA | 2 | 2011–2012 |
| Canton, MI, US | 1 | 2021 |